Name: CNMD Income Statement - Conmed Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CNMD - Conmed Corp.

USD | NYSE | Healthcare

CNMD Income Statement - Conmed Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16	Q1 FY 16
Revenues
Revenues	373.2	337.9	342.3	321.3	345.9	316.7	332.1	312.3	327.0	304.6	317.7	295.5	250.9	275.1	277.2	242.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	14.9	13.9	14.1	12.9	13.2	13.6	14.1	13.6	14.0	12.5	13.6	12.5	12.2	12.8	11.5	10.7	11.4	10.9	11.3	10.0	11.7	9.9	8.7	10.1	12.1	11.0	11.8	10.6	10.4	14.1	10.0	7.7	8.4	8.3	8.0	7.6	7.6	8.4	8.0	8.3
Selling General & Administrative	166.8	140.3	136.0	148.8	132.7	99.7	122.5	123.4	118.0	125.3	129.7	130.1	120.7	114.6	115.8	102.9
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	34.4	31.9	33.0	32.7	28.1	28.4	29.2	31.8	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	-	-	-	4.2	-	-	-	4.0	-	-	-	4.1	-	-	-	4.0
Amortization of Intangibles	9.1	8.7	8.7	8.7	8.7	8.8	8.6	8.6	8.9	8.7	8.8	8.8	8.8	8.7	8.2	8.0	8.5
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	181.7	154.2	150.2	161.8	145.8	113.3	136.6	137.0	132.0	137.8	143.3	142.6	133.0	127.4	127.3	113.5

Operating Income
Operating Income	36.6	11.9	38.2	16.0	52.5	65.7	47.1	35.0	50.2	30.3	27.4	12.7	(1.1)	24.2	24.5	22.4	37.2	26.7	25.7	20.1	24.7	29.4	(21.2)	13.2	27.9	20.9	18.7	11.6	25.8	11.5	16.7	17.3	23.2	13.5	12.8	(2.5)	12.6	13.8	7.7	3.5

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	7.4	7.6	7.8	8.3	8.9	9.3	9.6	9.6	9.5	10.0	10.0	10.3	9.4	8.5	5.9	5.0	7.6	8.1
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	29.3	4.3	29.9	7.7	43.6	56.5	37.5	25.4	40.7	20.3	17.4	2.4	(10.5)	15.7	(93.5)	17.4	29.6

Tax & Net
Income Tax Expense	12.5	1.4	8.5	1.6	9.9	7.5	7.5	5.7	7.6	4.4	3.7	0.6	(37.1)	(30.4)	74.8	2.5	5.2	2.5	3.0	(0.1)	(10.6)	10.5	(5.3)	(2.4)	2.3	2.5	0.8	(3.0)	4.6	0.5	2.9	1.8	(28.4)	1.5	2.2	(2.1)	2.0	2.6	1.0	(1.0)
Net Income From Continuing Ops	16.7	2.9	21.4	6.0	33.8	49.0	30.0	19.7	33.1	15.8	13.7	1.8	26.6	46.2	(168.3)	15.0	24.4
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	16.7	2.9	21.4	6.0	33.8	49.0	30.0	19.7	33.1	15.8	13.7	1.8	26.6	46.2	(168.3)	15.0	24.4
Net Income Attributable To Parent	16.7	2.9	21.4	6.0	33.8	49.0	30.0	19.7	33.1	15.8	13.7	1.8	26.6	46.2	(168.3)	15.0
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	16.7	2.9	21.4	6.0	33.8	49.0	30.0	19.7	33.1	15.8	13.7	1.8	26.6	46.2	(168.3)

Per Share
EPS Basic	-	0.09	0.69	0.19	-	1.59	0.97	0.64	-	0.52	0.45	0.06	-	1.51	(5.65)	0.51	-	0.51	0.46	0.34	-	0.24	(0.96)	0.21	-	0.25	0.20	0.04	-	0.21	0.31	0.38	-	0.26	0.22	(0.16)	-	0.26	0.10	(0.08)
EPS Diluted	-	0.09	0.69	0.19	-	1.57	0.96	0.63	-	0.50	0.43	0.06	-	1.48	(5.65)	0.47	-	0.47
Shares Basic	-	31.0	30.9	31.0	-	30.9	30.8	30.8	-	30.7	30.7	30.5	-	30.5	29.8	29.4	-	29.2
Shares Diluted	-	31.1	31.1	31.2	-	31.1	31.1	31.3	-	31.7	31.8	31.2	-	31.1	29.8	35.2	-	32.1

Supplementary Data
EBITDA	-	-	-	20.2	-	-	-	39.1	-	-	-	16.8	-	-	-	26.5	-	-	-	24.8	-	-	-	17.8	-	-	-	16.1	-	-	-	21.8	-	-	-	2.4	-	-	-	8.5
EBIT	36.6	11.9	38.2	16.0	52.5	65.7	47.1	35.0	50.2	30.3	27.4	12.7	(1.1)	24.2	24.5	22.4	37.2	26.7	25.7

Operating Expenses
Research & Development	55.9	54.4	52.6	47.2	43.6	40.5	45.5	42.2	32.3	32.3	27.4	27.8	25.8	28.2	28.7	29.7	31.8
Selling General & Administrative	592.0	478.3	503.0	454.0	414.8	373.8	400.1	355.6	351.8	338.4	303.1	323.5	330.1	302.5	276.6	276.5
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	132.0	117.5	111.2	96.1	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	17.1	16.6	16.2	16.1	16.5	18.0	18.7	18.5	20.1	20.5	18.7	19.8	18.7	18.6	18.5	17.4
Amortization of Intangibles	35.2	34.7	35.2	33.7	33.3	34.2	32.3	23.2	21.3	20.0	12.6	13.0	13.7	13.8	6.5	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	24.0	13.4	10.0	1.1	2.2	-
Total Operating Expenses	647.9	532.7	555.6	501.2	458.3	414.3	445.6	397.8	384.1	370.7	330.5	351.3	355.9	340.6	366.7	308.3

Operating Income
Operating Income	102.6	200.3	120.6	70.1	109.7	46.0	79.1	71.3	46.9	37.7	51.2	52.8	56.5	65.2	8.3	57.1	28.3

Tax & Net
Income Tax Expense	24.1	30.6	16.4	9.7	10.6	(7.9)	2.6	9.8	(26.8)	4.7	14.6	14.5	14.7	19.0	(3.1)	15.3	6.0
Net Income From Continuing Ops	47.1	132.4	64.5	(80.6)	62.5	9.5	28.6	40.9	55.5	14.7	30.5	32.2	35.9	40.5	0.8	30.3	12.1
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	47.1	132.4	64.5	(80.6)	62.5	9.5	28.6	40.9	55.5	14.7	30.5	32.2	35.9	40.5	0.8	30.3	12.1
Net Income Attributable To Parent	47.1	132.4	64.5	(80.6)	62.5	9.5	28.6	40.9	55.5	14.7	30.5	32.2	35.9	40.5	0.8	30.3
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	47.1	132.4	64.5	(80.6)	62.5	9.5	28.6	40.9	55.5	14.7	30.5	32.2	35.9	40.5	0.8

Per Share
EPS Basic	1.52	4.29	2.10	(2.68)	2.14	0.33	1.01	1.45	1.99	0.53	1.10	1.17	1.30	1.43	0.03	1.06	0.42
EPS Diluted	1.51	4.25	2.04	(2.68)	1.94	0.32	0.97	1.41	1.97	0.52	1.09	1.16	1.28	1.41	0.03	1.05	0.42
Shares Basic	31.0	30.8	30.7	30.0	29.2	28.6	28.3	28.1	27.9	27.8	27.7	27.4	27.7	28.3	28.2	28.7	29.1
Shares Diluted	31.1	31.2	31.5	30.0	32.2	29.5	29.5	28.9	28.2	28.0	27.9	27.8	28.1	28.7	28.6	28.9	29.1

Supplementary Data
EBITDA	119.8	216.9	136.8	86.1	126.2	64.1	97.8	89.8	67.0	58.2	69.9	72.6	75.2	83.8	26.8	74.5	46.9
EBIT	102.6	200.3	120.6	70.1	109.7	46.0	79.1	71.3	46.9	37.7	51.2	52.8	56.5	65.2	8.3	57.1	28.3

(in millions of USD, except per-share data)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues